Compare GKOS & MNSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GKOS | MNSO |
|---|---|---|
| Founded | 1998 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 6.0B |
| IPO Year | 2015 | 2020 |
| Metric | GKOS | MNSO |
|---|---|---|
| Price | $120.64 | $19.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 2 |
| Target Price | ★ $127.71 | $24.10 |
| AVG Volume (30 Days) | ★ 677.3K | 427.5K |
| Earning Date | 02-17-2026 | 11-20-2025 |
| Dividend Yield | N/A | ★ 3.20% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.98 |
| Revenue | $469,820,000.00 | ★ $2,795,603,723.00 |
| Revenue This Year | $31.33 | $27.54 |
| Revenue Next Year | $24.01 | $19.30 |
| P/E Ratio | ★ N/A | $19.71 |
| Revenue Growth | ★ 30.38 | 23.44 |
| 52 Week Low | $73.16 | $13.95 |
| 52 Week High | $163.71 | $26.74 |
| Indicator | GKOS | MNSO |
|---|---|---|
| Relative Strength Index (RSI) | 64.15 | 44.52 |
| Support Level | $93.96 | $19.52 |
| Resistance Level | $115.00 | $19.84 |
| Average True Range (ATR) | 4.48 | 0.35 |
| MACD | -0.42 | 0.04 |
| Stochastic Oscillator | 94.40 | 32.02 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
MINISO Group Holding Ltd is a value retailer offering a variety of trendy lifestyle products featuring IP design. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying, and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying, and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.